Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
32.24 MXN
39.18 B MXN
133.78 B MXN
612.16 M
About CHUGAI PHARMACEUTICAL CO
Sector
CEO
Osamu Okuda
Headquarters
Tokyo
Website
Founded
1925
ISIN
JP3519400000
FIGI
BBG012VHDLR2
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.
4519:TSE - CHUGAI PHARMACEUTICAL - Up 145% over 12 months.Japanese listed Chugai Pharmaceutical is in a nice steady up trend. Could be worth a watch.
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of the pharmaceuticals. Its operations are carried out through the following business
4519, Chugai Pharmaceutical Co. - Trailing StopTSE:4519
The upward trend of one of our trades in the Japanese market continues.
We follow as always the not realized profit by ensuring more and more a Risk Reward as optimal as possible.
Good trading at all!
4519, Chugai Pharmaceutical Co. - Breakout on ascending triangleTSE:4519
Net breakout of the resistance of this ascending triangle.
As always, one of the parameters for deciding whether or not to enter our trade is the Yield Risk ratio, in which winning trades allow us both to compensate for the small losses we make 60% of the time and to create that extra marg
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4519/N is 842.54 MXN — it hasn't changed in the past 24 hours. Watch CHUGAI PHARMACEUTICAL CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange CHUGAI PHARMACEUTICAL CO stocks are traded under the ticker 4519/N.
4519/N stock hasn't changed in a week, the month change is a −8.89% fall, over the last year CHUGAI PHARMACEUTICAL CO has showed a 48.36% increase.
We've gathered analysts' opinions on CHUGAI PHARMACEUTICAL CO future price: according to them, 4519/N price has a max estimate of 1,335.21 MXN and a min estimate of 606.91 MXN. Watch 4519/N chart and read a more detailed CHUGAI PHARMACEUTICAL CO stock forecast: see what analysts think of CHUGAI PHARMACEUTICAL CO and suggest that you do with its stocks.
4519/N reached its all-time high on Oct 23, 2024 with the price of 924.70 MXN, and its all-time low was 528.81 MXN and was reached on May 14, 2024. View more price dynamics on 4519/N chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4519/N stock is 0.00% volatile and has beta coefficient of 1.00. Track CHUGAI PHARMACEUTICAL CO stock price on the chart and check out the list of the most volatile stocks — is CHUGAI PHARMACEUTICAL CO there?
Today CHUGAI PHARMACEUTICAL CO has the market capitalization of 1.45 T, it has decreased by −2.05% over the last week.
Yes, you can track CHUGAI PHARMACEUTICAL CO financials in yearly and quarterly reports right on TradingView.
CHUGAI PHARMACEUTICAL CO is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
4519/N earnings for the last quarter are 9.12 MXN per share, whereas the estimation was 8.28 MXN resulting in a 10.19% surprise. The estimated earnings for the next quarter are 7.53 MXN per share. See more details about CHUGAI PHARMACEUTICAL CO earnings.
CHUGAI PHARMACEUTICAL CO revenue for the last quarter amounts to 43.27 B MXN, despite the estimated figure of 40.63 B MXN. In the next quarter, revenue is expected to reach 37.37 B MXN.
4519/N net income for the last quarter is 15.01 B MXN, while the quarter before that showed 12.75 B MXN of net income which accounts for 17.77% change. Track more CHUGAI PHARMACEUTICAL CO financial stats to get the full picture.
CHUGAI PHARMACEUTICAL CO dividend yield was 1.50% in 2023, and payout ratio reached 40.44%. The year before the numbers were 2.32% and 34.26% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 7.60 K employees. See our rating of the largest employees — is CHUGAI PHARMACEUTICAL CO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHUGAI PHARMACEUTICAL CO EBITDA is 73.89 B MXN, and current EBITDA margin is 40.26%. See more stats in CHUGAI PHARMACEUTICAL CO financial statements.
Like other stocks, 4519/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHUGAI PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHUGAI PHARMACEUTICAL CO technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHUGAI PHARMACEUTICAL CO stock shows the buy signal. See more of CHUGAI PHARMACEUTICAL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.